Childhood Cancer Incidence, New York State, 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 279.0 | 228.5 | 148.4 | 123.8 | 183.4 | 145.2 | 323.6 | 235.8 | 610.8 | 164.7 | 5.8 | 934.4 | 182.6 | 5.2 |
| I Leukemias | 101.4 | 83.0 | 46.6 | 38.9 | 39.6 | 31.3 | 46.2 | 33.7 | 187.6 | 50.6 | 3.2 | 233.8 | 46.3 | 2.7 |
| I(a) Lymphoid leukemias | 77.6 | 63.6 | 37.8 | 31.5 | 26.4 | 20.9 | 23.8 | 17.3 | 141.8 | 38.3 | 2.8 | 165.6 | 33.0 | 2.2 |
| I(b) Acute myeloid leukemia | 13.6 | 11.1 | 4.0 | 3.3 | 7.4 | 5.9 | 10.2 | 7.4 | 25.0 | 6.7 | 1.2 | 35.2 | 6.9 | 1.0 |
| II Lymphomas and reticuloendothelial neoplasms | 12.0 | 9.8 | 18.8 | 15.7 | 39.0 | 30.9 | 81.4 | 59.3 | 69.8 | 19.0 | 2.0 | 151.2 | 29.1 | 2.1 |
| II(a) Hodgkin lymphoma | 0.6 | 0.5 | 5.0 | 4.2 | 21.0 | 16.6 | 51.2 | 37.3 | 26.6 | 7.2 | 1.2 | 77.8 | 14.8 | 1.5 |
| II(b,c,d) Non-Hodgkin lymphomas | 11.0 | 9.0 | 13.6 | 11.3 | 17.8 | 14.1 | 29.8 | 21.7 | 42.4 | 11.5 | 1.6 | 72.2 | 14.1 | 1.5 |
| III CNS & misc intracranial & intraspinal neoplasms | 47.8 | 39.1 | 45.0 | 37.5 | 37.0 | 29.3 | 36.2 | 26.4 | 129.8 | 35.2 | 2.7 | 166.0 | 33.0 | 2.2 |
| III(a) Ependymomas and choroid plexus tumor | 6.2 | 5.1 | 2.8 | 2.3 | 2.0 | 1.6 | 2.6 | 1.9 | 11.0 | 3.0 | 0.8 | 13.6 | 2.7 | 0.6 |
| III(b) Astrocytoma | 22.4 | 18.3 | 22.8 | 19.0 | 23.2 | 18.4 | 20.0 | 14.6 | 68.4 | 18.6 | 2.0 | 88.4 | 17.6 | 1.6 |
| III(c) Intracranial and intraspinal embryonal tum | 12.8 | 10.5 | 9.8 | 8.2 | 4.2 | 3.3 | 3.0 | 2.2 | 26.8 | 7.3 | 1.2 | 29.8 | 6.0 | 1.0 |
| III(d) Other gliomas | 5.2 | 4.3 | 8.4 | 7.0 | 6.2 | 4.9 | 7.8 | 5.7 | 19.8 | 5.4 | 1.1 | 27.6 | 5.5 | 0.9 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 36.6 | 30.0 | 3.8 | 3.2 | 1.4 | 1.1 | 1.2 | 0.9 | 41.8 | 11.1 | 1.5 | 43.0 | 8.5 | 1.1 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 36.6 | 30.0 | 3.6 | 3.0 | 1.0 | 0.8 | 1.0 | 0.7 | 41.2 | 10.9 | 1.5 | 42.2 | 8.3 | 1.1 |
| V Retinoblastoma | 15.6 | 12.8 | 0.8 | 0.7 | 0.0 | 0.0 | 0.2 | 0.1 | 16.4 | 4.3 | 0.9 | 16.6 | 3.3 | 0.7 |
| VI Renal tumors | 25.2 | 20.6 | 4.6 | 3.8 | 2.6 | 2.1 | 3.4 | 2.5 | 32.4 | 8.6 | 1.3 | 35.8 | 7.1 | 1.0 |
| VI(a) Nephroblastoma and other nonepithelial rena | 25.2 | 20.6 | 4.0 | 3.3 | 1.0 | 0.8 | 0.4 | 0.3 | 30.2 | 8.0 | 1.3 | 30.6 | 6.1 | 1.0 |
| VII Hepatic tumors | 9.8 | 8.0 | 0.8 | 0.7 | 1.8 | 1.4 | 2.2 | 1.6 | 12.4 | 3.3 | 0.8 | 14.6 | 2.9 | 0.7 |
| VII(a) Hepatoblastoma | 9.8 | 8.0 | 0.2 | 0.2 | 0.6 | 0.5 | 0.0 | 0.0 | 10.6 | 2.8 | 0.8 | 10.6 | 2.1 | 0.6 |
| VIII Malignant bone tumors | 2.0 | 1.6 | 8.6 | 7.2 | 17.4 | 13.8 | 20.4 | 14.9 | 28.0 | 7.6 | 1.3 | 48.4 | 9.5 | 1.2 |
| VIII(a) Osteosarcoma | 0.2 | 0.2 | 4.6 | 3.8 | 10.0 | 7.9 | 13.0 | 9.5 | 14.8 | 4.0 | 0.9 | 27.8 | 5.4 | 0.9 |
| VIII(c) Ewing tumor and related sarcomas of bone | 1.6 | 1.3 | 3.2 | 2.7 | 4.2 | 3.3 | 4.8 | 3.5 | 9.0 | 2.5 | 0.7 | 13.8 | 2.7 | 0.6 |
| IX Soft tissue and other extraosseous sarcomas | 15.8 | 12.9 | 10.2 | 8.5 | 14.4 | 11.4 | 26.4 | 19.2 | 40.4 | 10.9 | 1.5 | 66.8 | 13.0 | 1.4 |
| IX(a) Rhabdomyosarcoma | 9.8 | 8.0 | 5.8 | 4.8 | 4.6 | 3.6 | 4.8 | 3.5 | 20.2 | 5.5 | 1.1 | 25.0 | 5.0 | 0.9 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 9.0 | 7.4 | 3.0 | 2.5 | 9.6 | 7.6 | 41.6 | 30.3 | 21.6 | 5.8 | 1.1 | 63.2 | 12.0 | 1.3 |
| X(a) Intracranial and intraspinal germ cell tumo | 1.4 | 1.1 | 0.6 | 0.5 | 3.2 | 2.5 | 3.8 | 2.8 | 5.2 | 1.4 | 0.5 | 9.0 | 1.7 | 0.5 |
| X(c) Malignant gonadal germ cell tumor | 2.4 | 2.0 | 2.0 | 1.7 | 5.8 | 4.6 | 30.2 | 22.0 | 10.2 | 2.8 | 0.8 | 40.4 | 7.6 | 1.0 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 2.4 | 2.0 | 6.2 | 5.2 | 20.0 | 15.8 | 63.4 | 46.2 | 28.6 | 7.8 | 1.3 | 92.0 | 17.4 | 1.6 |
| XI(b) Thyroid carcinoma | 0.2 | 0.2 | 2.0 | 1.7 | 9.2 | 7.3 | 32.6 | 23.8 | 11.4 | 3.1 | 0.8 | 44.0 | 8.3 | 1.1 |
| XI(d) Malignant melanoma | 1.0 | 0.8 | 2.4 | 2.0 | 3.8 | 3.0 | 13.2 | 9.6 | 7.2 | 2.0 | 0.6 | 20.4 | 3.9 | 0.8 |
| XII Other and unspecified malignant neoplasms | 1.4 | 1.1 | 0.0 | 0.0 | 0.6 | 0.5 | 1.0 | 0.7 | 2.0 | 0.5 | 0.3 | 3.0 | 0.6 | 0.3 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
